CHICAGO, May 28, 2024
/PRNewswire/ -- Linden Capital Partners, a Chicago-based healthcare private equity firm,
is pleased to announce a passive, minority investment from Blue
Owl's GP Strategic Capital platform and Lunate Capital via their
joint venture. Terms of the transaction were not disclosed.
Founded in 2004, Linden Capital Partners ("Linden") has grown to
become one of the largest dedicated healthcare private equity firms
in the US, through a model of partnership with management teams and
a rigorous Value Creation Program. Linden has approximately
$8.0 billion of regulatory assets
under management and has invested in over 45 healthcare companies
across more than 350 transactions. Linden invests in middle market
platforms in the targeted sub-sectors of healthcare services,
medical products, and specialty distribution.
Blue Owl's GP Strategic Capital platform provides minority
equity and financing solutions to private capital managers. The
platform has $55.8 billion of assets
under management and has completed over 85 equity and debt
transactions since its inception in 2010. Blue Owl's Business
Services Platform is also the largest post-transaction value
creation team in the GP Stakes industry.
Lunate Capital is an independent global alternative investment
manager with more than 170 employees and $105 billion of assets under management.
In February 2024, Blue Owl's GP
Strategic Capital platform formed a joint venture with Lunate. The
joint venture targets GPs with a clear sector specialization,
differentiated approach, strong leadership and culture, and an
established foundation of a durable, stable platform with
identifiable key drivers of franchise value.
The passive minority investment supports the continued growth of
Linden's investment platform and development of strategic
initiatives by bringing additional flexibility to the firm's
balance sheet. The investment will not have an impact on the
day-to-day management and investment strategies of Linden.
"Over the past 20 years, we have had a relentless focus on
supporting outstanding healthcare companies. Our goal of generating
exceptional value for business owners and investors continues as we
leverage our team of operating partners, investment professionals,
and industry network to drive growth across our portfolio," said
Tony Davis, Linden Co-Founder and
President. "Our strategic partnership with Blue Owl GP Strategic
Capital and Lunate, both of whom Linden considers to be industry
leaders in global private capital markets, marks another important
step in the continued development of our platform, at a time when
we see enormous opportunity to deliver further long-term
sustainable growth and value creation."
"We are excited to partner with Linden, one of the leading
specialist healthcare private equity platforms in the US," said
Michael D. Rees, Co-President and
Head of Blue Owl's GP Strategic Capital platform. "Linden's strong
investment track record, coupled with the firm's differentiated
partnership approach and strategic industry network give us
confidence in Linden's continued growth and success."
Linden was advised by Evercore as financial advisor and Kirkland
& Ellis as legal counsel. Blue Owl was advised by BofA
Securities as financial advisor and by Fried, Frank, Harris,
Shriver & Jacobson LLP as legal counsel.
About Linden
Linden Capital Partners is a Chicago-based private equity firm focused
exclusively on the healthcare industry. Founded in 2004, Linden is
the country's largest dedicated healthcare private equity firm by
total buyout capital raised. Linden's strategy is based upon three
elements: (i) healthcare specialization, (ii) integrated private
equity and operating expertise, and (iii) its differentiated human
capital program. Linden invests in middle market platforms in the
medical products, specialty distribution, pharmaceutical, and
services segments of healthcare. Since its founding, Linden has
invested in over 45 healthcare companies encompassing over 350
total transactions. The firm has approximately $8.0 billion in regulatory assets under
management. For more information, please visit
www.lindenllc.com.
About Blue Owl
Blue Owl (NYSE: OWL) is a leading asset
manager that is redefining alternatives.
With over $174 billion in assets
under management as of March 31,
2024, Blue Owl invests across three multi-strategy
platforms: Credit, GP Strategic Capital, and Real Estate. Anchored
by a strong permanent capital base, Blue Owl provides businesses
with private capital solution to drive long-term growth and offer
institutional and individual investors differentiated alternative
investment opportunities that aim to deliver strong performance,
risk-adjusted returns, and capital preservation.
Together with over 725 experienced professionals globally, Blue
Owl brings the vision and discipline to create the exceptional. To
learn more, visit www.blueowl.com.
About Lunate
Lunate is an Abu Dhabi-based, partner-led, independent
global alternative investment manager with more than 170 employees
and $105 billion of assets under
management. Lunate invests across the entire private markets
spectrum, including buyouts, growth equity, early and
late-stage venture capital, private credit, real assets, and public
equities and public credit. Lunate aims to be one of the world's
leading private markets solutions providers through SMAs
and multi-asset class funds, seeking to generate
best-in-class risk-adjusted returns for its clients. Lunate
recently established ALTÉRRA, the world's largest
private investment vehicle for climate change action, at
COP28. For more information,
please visit www.lunate.com
Contacts
Linden
IR@lindenllc.com
Blue Owl
Nick.Theccanat@blueowl.com
Lunate
Media@Lunate.com
View original
content:https://www.prnewswire.com/news-releases/linden-announces-minority-investment-from-blue-owls-gp-strategic-capital-platform-and-lunate-302156131.html
SOURCE Linden Capital Partners